BIO-TECHNE Corp Stock Repurchased During Period, Value
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BIO-TECHNE Corp stock repurchased during period, value for the quarter ending 2023-12-31 was $80.04M.
- BIO-TECHNE Corp stock repurchased during period, value for the quarter ending 2022-09-30 was $19.56M.
- BIO-TECHNE Corp stock repurchased during period, value for the quarter ending 2022-03-31 was $60.84M, a 40.90% increase year-over-year.
- BIO-TECHNE Corp stock repurchased during period, value for the quarter ending 2021-12-31 was $41.29M.
- BIO-TECHNE Corp stock repurchased during period, value for fiscal 2024 was $80.04M, a 309.17% increase from fiscal 2023.
- BIO-TECHNE Corp stock repurchased during period, value for fiscal 2023 was $19.56M, a 87.85% decline from fiscal 2022.
- BIO-TECHNE Corp stock repurchased during period, value for fiscal 2022 was $160.95M, a 272.76% increase from fiscal 2021.
- BIO-TECHNE Corp stock repurchased during period, value for fiscal 2021 was $43.18M, a 13.84% decline from fiscal 2020.
| Period end | Stock Repurchased During Period, Value 3 month | Stock Repurchased During Period, Value 12 month |
|---|---|---|
| 2024-06-30 | $80.04M 10-K · filed 2024-08-22 | |
| 2023-12-31 | $80.04M 10-Q · filed 2024-05-06 | |
| 2023-06-30 | $19.56M 10-K · filed 2024-08-22 | |
| 2022-09-30 | $19.56M 10-Q · filed 2024-05-06 | |
| 2022-06-30 | $160.95M 10-K · filed 2024-08-22 | |
| 2022-03-31 | $60.84M 10-Q · filed 2023-05-08 | |
| 2021-12-31 | $41.29M 10-Q · filed 2023-05-08 | |
| 2021-06-30 | $43.18M 10-K · filed 2023-08-23 | |
| 2021-03-31 | $43.18M 10-Q · filed 2022-05-09 | |
| 2020-06-30 | $50.11M 10-K · filed 2022-08-24 | |
| 2020-03-31 | $50.11M 10-Q · filed 2021-05-07 | |
| 2019-06-30 | $15.40M 10-K · filed 2021-08-25 | |
| 2013-06-30 | $1.82M 10-K · filed 2015-08-31 | |
| 2012-06-30 | $23.60M 10-K · filed 2014-08-29 | |
| 2010-06-30 | $16.91M 10-K · filed 2012-08-29 | |
| 2009-06-30 | $90.63M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |